Literature DB >> 2912189

Relation between phosphate metabolites and oxygen consumption of heart in vivo.

L A Katz1, J A Swain, M A Portman, R S Balaban.   

Abstract

The relation between induced increases in cardiac work and phosphate metabolites was investigated in the canine heart in vivo to evaluate the role of ATP hydrolysis products, ADP and inorganic phosphate (Pi), in the control of myocardial oxygen consumption (MVO2). In these studies, myocardial blood flow and oxygen consumption were simultaneously measured with the 31P-nuclear magnetic resonance (NMR)-detected phosphate metabolites. Three protocols were used to increase myocardial work: pacing, epinephrine, and phenylephrine infusions. When these protocols were used, no or only slight changes in myocardial ATP, Pi, and creatine phosphate were observed with a greater than threefold increase in MVO2. The calculated intracellular free Mg concentration, ADP, and pH were also only slightly affected by these increases in work. These data indicate that a simple model involving the feedback of cytosolic ADP and Pi to the mitochondria regulating respiration is inadequate to explain respiratory control in vivo. These data suggest that some other parameters or cooperativity effects involving the phosphate metabolites must play a role in the feedback between respiration and work in the heart in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912189     DOI: 10.1152/ajpheart.1989.256.1.H265

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  91 in total

1.  Muscle ATP synthesis and utilisation, balanced during flow-induced increase of respiration.

Authors:  A Janovská; J A Mejsnar; B Stefl
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Impaired ATP kinetics in failing in vivo mouse heart.

Authors:  Ashish Gupta; Vadappuram P Chacko; Michael Schär; Ashwin Akki; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 7.792

3.  Developmental changes in regulation of mitochondrial respiration by ADP and creatine in rat heart in vivo.

Authors:  T Tiivel; L Kadaya; A Kuznetsov; T Käämbre; N Peet; P Sikk; U Braun; R Ventura-Clapier; V Saks; E K Seppet
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

4.  Training-induced adaptation of oxidative phosphorylation in skeletal muscles.

Authors:  Bernard Korzeniewski; Jerzy A Zoladz
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 5.  Kinetic studies of ATP synthase: the case for the positional change mechanism.

Authors:  K F LaNoue; J Duszynski
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

6.  Regulation of oxidative phosphorylation complex activity: effects of tissue-specific metabolic stress within an allometric series and acute changes in workload.

Authors:  Darci Phillips; Raul Covian; Angel M Aponte; Brian Glancy; Joni F Taylor; David Chess; Robert S Balaban
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

Review 7.  Mitochondrial dynamics in heart disease.

Authors:  Gerald W Dorn
Journal:  Biochim Biophys Acta       Date:  2012-03-16

Review 8.  Slow VO₂ kinetics during moderate-intensity exercise as markers of lower metabolic stability and lower exercise tolerance.

Authors:  Bruno Grassi; Simone Porcelli; Desy Salvadego; Jerzy A Zoladz
Journal:  Eur J Appl Physiol       Date:  2010-09-07       Impact factor: 3.078

9.  Faster O₂ uptake kinetics in canine skeletal muscle in situ after acute creatine kinase inhibition.

Authors:  Bruno Grassi; Harry B Rossiter; Michael C Hogan; Richard A Howlett; James E Harris; Matthew L Goodwin; John L Dobson; L Bruce Gladden
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

10.  Ca2+-regulated-cAMP/PKA signaling in cardiac pacemaker cells links ATP supply to demand.

Authors:  Yael Yaniv; Magdalena Juhaszova; Alexey E Lyashkov; Harold A Spurgeon; Steven J Sollott; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2011-07-28       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.